Short Communication - (2025) Volume 12, Issue 4
Received: 01-Aug-2025, Manuscript No. jpd-26-183932;
Editor assigned: 04-Aug-2025, Pre QC No. P-183932;
Reviewed: 18-Aug-2025, QC No. Q-183932;
Revised: 22-Aug-2025, Manuscript No. R-183932;
Published:
29-Aug-2025
, DOI: 10.37421/2684-4281.2025.12.538
Citation: Alvarez, Mateo J.. ”Hormones and Skin: A Complex Connection.” J Dermatol Dis 12 (2025):538.
Copyright: © 2025 Alvarez J. Mateo This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
The intricate interplay between the endocrine system and skin health is a subject of profound clinical significance, necessitating a comprehensive understanding of the dermatologic manifestations arising from hormonal dysregulation. Endocrine disorders, affecting glands such as the thyroid, adrenal glands, ovaries, and testes, can precipitate a diverse array of cutaneous changes that serve as crucial diagnostic indicators. This review aims to elucidate these connections, underscoring the importance of recognizing these dermatologic signs for timely and accurate diagnosis and effective management of a broad spectrum of skin diseases [1].
Among the most prevalent endocrine-related skin conditions is acne vulgaris, which exhibits a marked association with androgen excess, particularly in the context of polycystic ovary syndrome (PCOS). The underlying pathophysiological mechanisms involve increased sebum production, follicular hyperkeratinization, and inflammation, all of which are driven by elevated androgen levels. Understanding these pathways is essential for tailoring treatments that address both the hormonal imbalance and the resulting acne severity [2].
Thyroid dysfunction represents another significant endocrine influence on skin health, presenting with a wide range of dermatologic symptoms in both hypothyroidism and hyperthyroidism. These can include alterations in skin texture, temperature, moisture, and hair loss, highlighting the thyroid gland's critical role in maintaining normal cutaneous function. Early identification of these cutaneous signs can facilitate the prompt diagnosis of thyroid disorders, leading to improved patient outcomes [3].
The menopausal transition, characterized by a significant decline in estrogen levels, profoundly impacts skin aging. This hormonal shift leads to decreased skin thickness, reduced collagen synthesis, impaired wound healing, and increased dryness and wrinkling. Recognizing these age-related dermatologic changes is vital for addressing the concerns of women during this life stage and for exploring potential therapeutic interventions [4].
Disorders of the adrenal glands, such as Cushing's syndrome and Addison's disease, also present with distinct dermatologic features. Cushing's syndrome may manifest as skin thinning, easy bruising, and striae, while Addison's disease can result in generalized hyperpigmentation. These cutaneous signs are invaluable in the diagnostic workup of adrenal pathology, providing tangible clues to underlying hormonal imbalances [5].
Beyond the classical endocrine glands, the growth hormone (GH) and insulin-like growth factor 1 (IGF-1) axis also exerts a considerable influence on skin physiology. Deficiencies or excesses in GH and IGF-1 can lead to characteristic dermatologic findings, including changes in skin texture, hydration, and the propensity for certain skin lesions. Understanding the role of the GH axis in skin health is crucial for a holistic approach to endocrine-dermatologic assessment [6].
In men, testosterone plays a pivotal role in maintaining healthy skin, affecting sebum production, hair growth, and wound healing. Disruptions in testosterone levels, whether deficiency or excess, can lead to specific dermatologic conditions such as androgenetic alopecia and acne. A thorough evaluation of androgen status is therefore important in the management of male dermatological concerns [7].
Polycystic ovary syndrome (PCOS) stands out as a complex endocrine disorder with a constellation of dermatologic manifestations, predominantly acne, hirsutism, and androgenetic alopecia. The hormonal milieu of PCOS, marked by elevated androgens, directly contributes to these visible skin conditions, necessitating a multidisciplinary approach to management that integrates dermatological and gynecological expertise [8].
The broad spectrum of endocrine-dermatologic associations underscores the interconnectedness of these physiological systems. Disruptions in major endocrine axes, including the hypothalamic-pituitary-adrenal (HPA) axis, the thyroid axis, and the gonadal axes, often manifest through the skin. This intricate interface highlights the diagnostic and therapeutic implications of considering hormonal status in dermatological evaluations [9].
Furthermore, metabolic disorders, fundamentally rooted in hormonal dysregulation, such as insulin resistance and diabetes mellitus, are associated with a distinct set of dermatologic consequences. These include conditions like acanthosis nigricans and diabetic dermopathy, as well as an increased susceptibility to infections, all linked to impaired insulin signaling and metabolic imbalances. Recognizing these skin manifestations can aid in the early detection and management of these systemic diseases [10].
Hormonal imbalances represent a significant determinant of skin health, manifesting in a wide variety of dermatologic conditions that require careful clinical consideration. Disorders affecting the thyroid, adrenal glands, ovaries, and testes can lead to specific and recognizable cutaneous changes, serving as vital diagnostic markers. The comprehensive review of these endocrine-dermatologic links is paramount for accurate diagnosis and effective therapeutic strategies across numerous skin diseases [1].
Acne vulgaris, a ubiquitous dermatological concern, is strongly correlated with androgen excess, a common feature in conditions like polycystic ovary syndrome (PCOS). This association is underpinned by the pathophysiological mechanisms where androgens stimulate increased sebum production, follicular hyperkeratinization, and inflammation, thereby contributing to acne development. Furthermore, the impact of hormonal therapies used for PCOS on acne severity is a critical aspect of its management [2].
Thyroid dysfunction frequently presents with a diverse range of dermatologic manifestations, affecting both hypothyroidism and hyperthyroidism. Cutaneous changes such as dry, pale skin, alopecia in hypothyroidism, and warm, moist skin, pretibial myxedema, and onycholysis in hyperthyroidism are key indicators. Recognizing these signs is crucial for the early diagnosis of thyroid disorders and for improving overall patient prognoses [3].
The menopausal transition is characterized by a substantial decline in estrogen levels, which has profound and visible effects on skin aging. These dermatologic consequences include a reduction in skin thickness, diminished collagen synthesis, impaired wound healing capabilities, and an increase in dryness and wrinkling. The potential benefits of hormone replacement therapy for mitigating these skin changes are also a subject of ongoing research [4].
Adrenal disorders, including Cushing's syndrome and Addison's disease, are associated with characteristic dermatologic presentations. Cushing's syndrome often presents with skin thinning, ecchymoses, characteristic purple striae, and acne. In contrast, Addison's disease may lead to generalized hyperpigmentation. These distinct cutaneous signs play a significant role in the diagnostic evaluation of adrenal pathology [5].
The growth hormone (GH) and insulin-like growth factor 1 (IGF-1) axis also plays a crucial role in skin physiology, influencing its structure and function. GH deficiency can result in dry, wrinkled skin and delayed wound healing, while acromegaly (excess GH) may lead to thickened skin and hyperhidrosis. These findings highlight the dermatologic relevance of GH axis disorders [6].
Testosterone is a vital hormone for male skin physiology, impacting sebaceous gland activity, hair follicle development, and wound repair processes. Both testosterone deficiency, as seen in andropause, and conditions of androgen excess can lead to specific dermatologic issues in men, including androgenetic alopecia and acne. These conditions necessitate an assessment of androgen levels [7].
Polycystic ovary syndrome (PCOS) is a multifaceted endocrine disorder with prominent dermatologic manifestations, including acne, hirsutism, and androgenetic alopecia. The hormonal imbalances inherent in PCOS, particularly elevated androgen levels, are the primary drivers of these skin conditions. Effective management requires a multidisciplinary approach that addresses both endocrine and dermatologic aspects [8].
The complex relationship between the endocrine system and skin health is further exemplified by the consequences of disruptions in various endocrine axes, such as the hypothalamic-pituitary-adrenal (HPA) axis, the thyroid axis, and the gonadal axes. These disruptions often translate into observable dermatologic changes, reinforcing the importance of an integrated diagnostic and therapeutic approach [9].
Finally, insulin resistance and diabetes mellitus, which are fundamentally endocrine and metabolic disorders, have significant dermatologic ramifications. These include the development of acanthosis nigricans, diabetic dermopathy, and an increased predisposition to infections, all of which are linked to dysregulated insulin signaling and hormonal imbalances associated with metabolic syndrome [10].
The endocrine system profoundly influences skin health, with hormonal imbalances leading to diverse dermatologic conditions. Disorders of the thyroid, adrenal glands, ovaries, and testes manifest in specific skin changes, such as dry skin in hypothyroidism, acne in androgen excess, and skin thinning during menopause due to estrogen deficiency. Conditions like PCOS are strongly linked to androgen excess, causing acne and hair loss. Adrenal disorders like Cushing's syndrome present with skin thinning and bruising, while Addison's disease can cause hyperpigmentation. Growth hormone imbalances also affect skin texture and wound healing. Testosterone deficiency in men can lead to hair loss and skin issues. Diabetes and insulin resistance are associated with conditions like acanthosis nigricans and increased infection risk. Recognizing these endocrine-dermatologic connections is crucial for accurate diagnosis and effective management of a wide range of skin diseases.
None
None
Journal of Dermatology and Dermatologic Diseases received 4 citations as per Google Scholar report
